FDA 483 - Lisa Connery - January 08, 2026

An FDA inspection of Lisa Connery, a clinical investigator in Norman, OK, revealed a significant deviation from the investigational plan. Site staff mistakenly provided incorrect dosing instructions to multiple study participants for an investigational product, leading to subjects receiving an unintended dose. This indicates a failure to conduct the investigation in accordance with the approved protocol.